Prestige Consumer Healthcare Net Income 2011-2025 | PBH
Prestige Consumer Healthcare net income from 2011 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
|
Prestige Consumer Healthcare Annual Net Income (Millions of US $) |
|
|---|---|
| 2025 | $215 |
| 2024 | $209 |
| 2023 | $-82 |
| 2022 | $205 |
| 2021 | $165 |
| 2020 | $142 |
| 2019 | $-36 |
| 2018 | $340 |
| 2017 | $69 |
| 2016 | $100 |
| 2015 | $78 |
| 2014 | $73 |
| 2013 | $66 |
| 2012 | $37 |
| 2011 | $29 |
|
Prestige Consumer Healthcare Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2025-06-30 | $47 |
| 2025-03-31 | $50 |
| 2024-12-31 | $61 |
| 2024-09-30 | $54 |
| 2024-06-30 | $49 |
| 2024-03-31 | $49 |
| 2023-12-31 | $53 |
| 2023-09-30 | $54 |
| 2023-06-30 | $53 |
| 2023-03-31 | $-241 |
| 2022-12-31 | $52 |
| 2022-09-30 | $51 |
| 2022-06-30 | $55 |
| 2022-03-31 | $52 |
| 2021-12-31 | $50 |
| 2021-09-30 | $45 |
| 2021-06-30 | $58 |
| 2021-03-31 | $36 |
| 2020-12-31 | $41 |
| 2020-09-30 | $45 |
| 2020-06-30 | $44 |
| 2020-03-31 | $37 |
| 2019-12-31 | $38 |
| 2019-09-30 | $33 |
| 2019-06-30 | $34 |
| 2019-03-31 | $-139 |
| 2018-12-31 | $38 |
| 2018-09-30 | $31 |
| 2018-06-30 | $34 |
| 2018-03-31 | $-40 |
| 2017-12-31 | $315 |
| 2017-09-30 | $31 |
| 2017-06-30 | $34 |
| 2017-03-31 | $11 |
| 2016-12-31 | $32 |
| 2016-09-30 | $32 |
| 2016-06-30 | $-6 |
| 2016-03-31 | $14 |
| 2015-12-31 | $28 |
| 2015-09-30 | $32 |
| 2015-06-30 | $26 |
| 2015-03-31 | $24 |
| 2014-12-31 | $21 |
| 2014-09-30 | $16 |
| 2014-06-30 | $17 |
| 2014-03-31 | $16 |
| 2013-12-31 | $3 |
| 2013-09-30 | $33 |
| 2013-06-30 | $21 |
| 2013-03-31 | $19 |
| 2012-12-31 | $12 |
| 2012-09-30 | $19 |
| 2012-06-30 | $15 |
| 2012-03-31 | $0 |
| 2011-12-31 | $10 |
| 2011-09-30 | $13 |
| 2011-06-30 | $15 |
| 2011-03-31 | $6 |
| 2010-12-31 | $2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.885B | $1.138B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $224.767B | 25.90 |
| EssilorLuxottica (ESLOY) | France | $171.623B | 0.00 |
| Boston Scientific (BSX) | United States | $155.627B | 35.59 |
| Stryker (SYK) | United States | $142.805B | 28.35 |
| Medtronic (MDT) | Ireland | $123.317B | 17.39 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.676B | 0.00 |
| Agilent Technologies (A) | United States | $41.643B | 26.95 |
| ResMed (RMD) | United States | $36.793B | 25.47 |
| GE HealthCare Technologies (GEHC) | United States | $33.695B | 16.11 |
| Koninklijke Philips (PHG) | Netherlands | $27.848B | 18.19 |
| Insulet (PODD) | United States | $23.402B | 72.64 |
| Terumo (TRUMY) | Japan | $22.490B | 25.32 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.949B | 11.19 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.072B | 0.00 |
| Baxter (BAX) | United States | $9.613B | 7.76 |
| Sunny Optical Technology (SNPTF) | China | $9.361B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.548B | 30.74 |
| Demant (WILYY) | Denmark | $7.346B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.522B | 10.73 |
| Haemonetics (HAE) | United States | $3.460B | 15.40 |
| ICU Medical (ICUI) | United States | $3.420B | 21.71 |
| Envista Holdings (NVST) | United States | $3.270B | 18.76 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.034B | 40.93 |
| Perrigo (PRGO) | Ireland | $1.923B | 4.82 |
| Phibro Animal Health (PAHC) | United States | $1.812B | 18.10 |
| Curaleaf Holdings (CURLF) | Canada | $1.735B | 0.00 |
| AtriCure (ATRC) | United States | $1.577B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.507B | 9.69 |
| Neogen (NEOG) | United States | $1.384B | 26.54 |
| Green Thumb Industries (GTBIF) | United States | $1.379B | 60.46 |
| Kestra Medical Technologies (KMTS) | United States | $1.282B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.269B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.264B | 18.29 |
| BioLife Solutions (BLFS) | United States | $1.210B | 359.14 |
| InMode (INMD) | Israel | $0.904B | 10.21 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.831B | 0.00 |
| Valneva SE (VALN) | France | $0.794B | 0.00 |
| Surmodics (SRDX) | United States | $0.592B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.499B | 17.17 |
| Evolus (EOLS) | United States | $0.478B | 0.00 |
| CeriBell (CBLL) | United States | $0.463B | 0.00 |
| SNDL (SNDL) | Canada | $0.447B | 0.00 |
| Omeros (OMER) | United States | $0.427B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.427B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.381B | 0.00 |
| Cerus (CERS) | United States | $0.307B | 0.00 |
| Brainsway (BWAY) | Israel | $0.304B | 53.37 |
| Sanuwave Health (SNWV) | United States | $0.288B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.264B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.264B | 0.00 |
| High Tide (HITI) | Canada | $0.250B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.249B | 146.33 |
| Quanterix (QTRX) | United States | $0.249B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.244B | 19.42 |
| Owens & Minor (OMI) | United States | $0.227B | 2.27 |
| TriSalus Life Sciences (TLSI) | United States | $0.219B | 0.00 |
| Exagen (XGN) | United States | $0.212B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.191B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 15.85 |
| Sanara MedTech (SMTI) | United States | $0.175B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.173B | 21.33 |
| OraSure Technologies (OSUR) | United States | $0.164B | 0.00 |
| Apyx Medical (APYX) | United States | $0.156B | 0.00 |
| Biote (BTMD) | United States | $0.119B | 5.20 |
| Jushi Holdings (JUSHF) | United States | $0.106B | 0.00 |
| MacroGenics (MGNX) | United States | $0.101B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 13.27 |
| Sharps Technology (STSS) | United States | $0.091B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 23.27 |
| Nephros (NEPH) | United States | $0.047B | 34.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Jin Medical (ZJYL) | China | $0.041B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Bonk (BNKK) | United States | $0.030B | 0.00 |
| United-Guardian (UG) | United States | $0.028B | 14.35 |
| Modular Medical (MODD) | United States | $0.027B | 0.00 |
| Zynex (ZYXI) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.010B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |